Table 3. Antiproliferative Activities Evaluated on Four Cell Lines: A-375 (Melanoma), A549 (Lung), HCT-116 (Colon), and HL-60 (Leukemia)a.
| Cytotoxicity
(IC50, μM) |
||||
|---|---|---|---|---|
| A-375 | A549 | HCT-116 | HL-60 | |
| camptothecin | 0.013 | 0.009 | 0.003 | 0.035 |
| etoposide | 0.24 | 0.59 | >10 | 0.86 |
| securinine 1 | 6.1 | >10 | >10 | >10 |
| 4h | 0.36 | 2.64 | 1.66 | 5.00 |
| 4q | 1.75 | > 10 | n. t. | >10 |
| 4v | 2.82 | 3.99 | 2.47 | >10 |
| 4s | 0.17 | 0.60 | 0.42 | 0.42 |
| 4r | 0.06 | 0.29 | 0.34 | 0.66 |
| 4w | 0.95 | 4.4 | n.t. | >10 |
n.t.: not tested.